BackCan-Fite Biopharma Overview

Can-Fite Biopharma Net Income

Profitability analysis for CANF.

Quarterly Net Income

-$2.44M
23.22% YoY

As of Jun 2025

Annual Net Income (TTM)

-$8.80M
19.36% YoY

Trailing 12 months ending Jun 2025

Average Net Income (Comparison Companies)

Loading

Net Income History

Loading

Net Income Comparison

Loading

Annual Net Income Growth Rate (%)

Loading...

Annual Net Income Growth (Absolute)

Loading...